Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline

Background: Dementia can be caused by severe niacin insufficiency, but it is unknown whether variation in intake of niacin in the usual diet is linked to neurodegenerative decline. We examined whether dietary intake of niacin was associated with incident Alzheimer’s disease (AD) and cognitive decline in a large, prospective study. Methods: This study was conducted in 1993–2002 in a geographically defined Chicago community of 6158 residents aged 65 years and older. Nutrient intake was determined by food frequency questionnaire. Four cognitive tests were administered to all study participants at 3 year intervals in a 6 year follow up. A total of 3718 participants had dietary data and at least two cognitive assessments for analyses of cognitive change over a median 5.5 years. Clinical evaluations were performed on a stratified random sample of 815 participants initially unaffected by AD, and 131 participants were diagnosed with 4 year incident AD by standardised criteria. Results: Energy adjusted niacin intake had a protective effect on development of AD and cognitive decline. In a logistic regression model, relative risks (95% confidence intervals) for incident AD from lowest to highest quintiles of total niacin intake were: 1.0 (referent) 0.3 (0.1 to 0.6), 0.3 (0.1 to 0.7), 0.6 (0.3 to 1.3), and 0.3 (0.1 to 0.7) adjusted for age, sex, race, education, and ApoE e4 status. Niacin intake from foods was also inversely associated with AD (p for linear trend = 0.002 in the adjusted model). In an adjusted random effects model, higher food intake of niacin was associated with a slower annual rate of cognitive decline, by 0.019 standardised units (SU) per natural log increase in intake (mg) (p = 0.05). Stronger associations were observed in analyses that excluded participants with a history of cardiovascular disease (β = 0.028 SU/year; p = 0.008), those with low baseline cognitive scores (β = 0.023 SU/year; p = 0.02), or those with fewer than 12 years’ education (β = 0.035 SU/year; p = 0.002) Conclusion: Dietary niacin may protect against AD and age related cognitive decline.

[1]  Denis A. Evans,et al.  Validity and reproducibility of a food frequency questionnaire by cognition in an older biracial sample. , 2003, American journal of epidemiology.

[2]  C. J. Knill,et al.  McCance and Widdowson's the Composition of Foods sixth summary edition , 2003 .

[3]  D. Bennett,et al.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. , 2003, Archives of neurology.

[4]  D. Bennett,et al.  Dietary fats and the risk of incident Alzheimer disease. , 2003, Archives of neurology.

[5]  Denis A. Evans,et al.  Vitamin E and cognitive decline in older persons. , 2002, Archives of neurology.

[6]  A. Hofman,et al.  Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .

[7]  D. Bennett,et al.  Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study , 2022 .

[8]  K. Maiese,et al.  Nicotinamide Modulates Mitochondrial Membrane Potential and Cysteine Protease Activity during Cerebral Vascular Endothelial Cell Injury , 2002, Journal of Vascular Research.

[9]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[10]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[11]  R. Stierum,et al.  Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. , 2001, Mutation research.

[12]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[13]  H. Vannucchi,et al.  Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats. , 2000, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[14]  Nutrition Board,et al.  Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline , 2000 .

[15]  D. Bennett,et al.  The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  A. Guse Cyclic ADP-ribose: a novel Ca2+-mobilising second messenger. , 1999, Cellular signalling.

[17]  D. Bennett,et al.  Cognitive activity in older persons from a geographically defined population. , 1999, The journals of gerontology. Series B, Psychological sciences and social sciences.

[18]  L. Beckett,et al.  Current and remote blood pressure and cognitive decline. , 1999, JAMA.

[19]  G A Colditz,et al.  Response to a mail nutritional survey in an older bi-racial community population. , 1998, Annals of epidemiology.

[20]  A. Gass,et al.  Is There a Need to Reclassify Acute Stroke Patients? , 1998, Cerebrovascular Diseases.

[21]  G A Colditz,et al.  Validation of a youth/adolescent food frequency questionnaire. , 1997, Preventive medicine.

[22]  W. Herrmann,et al.  A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia. , 1997, Dementia and geriatric cognitive disorders.

[23]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.

[24]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[25]  P. Diggle Analysis of Longitudinal Data , 1995 .

[26]  E. Jacobson,et al.  Cyclic ADP-ribose. A new component of calcium signaling. , 1995, Receptor.

[27]  J. Kirkland,et al.  Dietary niacin deficiency lowers tissue poly(ADP-ribose) and NAD+ concentrations in Fischer-344 rats. , 1994, The Journal of nutrition.

[28]  G. Mihalas,et al.  Superiority of Antagonic‐Stress Composition versus Nicergoline in Gerontopsychiatry , 1994, Annals of the New York Academy of Sciences.

[29]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[30]  M. Albert,et al.  Neuropsychological and neurophysiological changes in healthy adult humans across the age range , 1993, Neurobiology of Aging.

[31]  Jean A.T. Pennington,et al.  McCance and widdowson's the composition of foods: 5th ed., edited by B. Holland, A. A. Welch, 1. D. Unwin, D. H. Buss, A. A. Paul, and D. A. T. Southgate. The Royal Society of Chemistry, Cambridge, 1991, 462 pp. $69.95 , 1992 .

[32]  P. Gorelick,et al.  Vascular dementias in the elderly. , 1991, Clinics in geriatric medicine.

[33]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[34]  M. Albert,et al.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. , 1991, The International journal of neuroscience.

[35]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[36]  A. Battaglia,et al.  Nicergoline in Mild to Moderate Dementia: A Multicenter, Double‐Blind, Placebo‐Controlled Study , 1989, Journal of the American Geriatrics Society.

[37]  G. Sacchetti,et al.  Nicergoline in Mild to Moderate Dementia , 1989 .

[38]  L R White,et al.  Correlates of cognitive function in an elderly community population. , 1988, American journal of epidemiology.

[39]  Meir J. Stampfer,et al.  Total energy intake: implications for epidemiologic analyses. , 1986, American journal of epidemiology.

[40]  D. Thomas,et al.  Tryptophan and nutritional status of patients with senile dementia , 1986, Psychological Medicine.

[41]  T. Esashi,et al.  Effect of 3-acetylpyridine on the development of rat brain. , 1985, Journal of nutritional science and vitaminology.

[42]  Criteria for the Clinical Diagnosis of Alzheimer's Disease Excerpts from the NINCDS‐ADRDA Work Group Report , 1985, Journal of The American Geriatrics Society.

[43]  Y. Nakashima,et al.  Influence of nicotinic acid on cerebroside synthesis in the brain of developing rats. , 1984, Journal of nutritional science and vitaminology.

[44]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[45]  S. Williams,et al.  Pilot Study of Amino Acids in Senile Dementia , 1981, British Journal of Psychiatry.

[46]  A. Paul,et al.  McCance and Widdowson's 'The composition of foods': dietary fibre in egg, meat and fish dishes. , 1979, Journal of human nutrition.

[47]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[48]  T. Stadtman,et al.  Vitamin B12 , 1971, Science.

[49]  F. H. Shillito,et al.  Department of Preventive Medicine , 1969 .

[50]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[51]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .